{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:23:41Z","timestamp":1761128621460},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1993,11,1]],"date-time":"1993-11-01T00:00:00Z","timestamp":752112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T00:00:00Z","timestamp":1484265600000},"content-version":"vor","delay-in-days":8474,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[1993,11]]},"DOI":"10.1378\/chest.104.5.1393","type":"journal-article","created":{"date-parts":[[2007,11,7]],"date-time":"2007-11-07T18:28:23Z","timestamp":1194460103000},"page":"1393-1399","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Efficacy and Safety of Clarithromycin Compared to Cefixime as Outpatient Treatment of Lower Respiratory Tract Infections"],"prefix":"10.1016","volume":"104","author":[{"given":"Harold C.","family":"Neu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas W.","family":"Chick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.104.5.1393_bib1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0163-4453(88)97556-1","article-title":"Distribution of serotypes and antibiotic resistance among pneumococci in Northern Ireland","volume":"16","author":"Lafong","year":"1988","journal-title":"J Infection"},{"key":"10.1378\/chest.104.5.1393_bib2","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/clinids\/9.6.1140","article-title":"Branhamella catarrhalis respiratory infections","volume":"9","author":"Hager","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.1378\/chest.104.5.1393_bib3","series-title":"Respiratory infections: diagnosis and management","first-page":"125","article-title":"Community-acquired pneumonia and acute bronchitis","author":"Pennington","year":"1983"},{"issue":"suppl 21","key":"10.1378\/chest.104.5.1393_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0002-9343(85)90257-8","article-title":"Treatment of community-acquired pneumonias","volume":"79","author":"McKellar","year":"1985","journal-title":"Am J Med"},{"key":"10.1378\/chest.104.5.1393_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(82)90334-8","article-title":"Hospital study of adult community acquired pneumonia","volume":"2","author":"MacFarlane","year":"1982","journal-title":"Lancet"},{"key":"10.1378\/chest.104.5.1393_bib6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/BF01962334","article-title":"Prospective study on the etiology of community-acquired pneumonia in children and adults in Spain","volume":"7","author":"Ausina","year":"1988","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1378\/chest.104.5.1393_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jac\/18.3.293","article-title":"The renaissance of erythromycin","volume":"18","author":"Malmborg","year":"1986","journal-title":"J Antimicrob Chemother"},{"issue":"suppl A","key":"10.1378\/chest.104.5.1393_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jac\/27.suppl_A.43","article-title":"The in vitro activity of clarithromycin and other macrolides against the type strain of Chlamydia pneumoniae (TWAR)","volume":"27","author":"Ridgway","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.104.5.1393_bib9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/jac\/19.6.841","article-title":"The antimicrobial activity of A-56268 (??-031) and roxithromycin (RU965) against Legionella using broth microdilution method","volume":"19","author":"Jones","year":"1987","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.104.5.1393_bib10","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1128\/AAC.33.9.1634","article-title":"In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp strain TWAR)","volume":"33","author":"Chirgwin","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1378\/chest.104.5.1393_bib11","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1128\/AAC.32.5.752","article-title":"In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin","volume":"32","author":"Barry","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1378\/chest.104.5.1393_bib12","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/AAC.30.6.865","article-title":"In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide","volume":"30","author":"Fernandes","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1378\/chest.104.5.1393_bib13","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/jac\/22.6.923","article-title":"An in vitro evaluation of the cellular uptake and intraphagocytic bioactivity of clarithromycin (A-56268, TE-031), a new macrolide antimicrobial agent","volume":"22","author":"Anderson","year":"1988","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.104.5.1393_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF02018203","article-title":"Comparative in vitro activity of A-56268 (TE-031) against gram-positive and gram-negative bacteria and Chlamydia trachomatis","volume":"6","author":"Benson","year":"1987","journal-title":"Eur J Clin Microbiol"},{"key":"10.1378\/chest.104.5.1393_bib15","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/BF02013122","article-title":"Comparative in vitro activity of A-56268 against respiratory tract pathogens","volume":"6","author":"Jansson","year":"1987","journal-title":"Eur J Clin Microbiol"},{"key":"10.1378\/chest.104.5.1393_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00003495-199244010-00009","article-title":"Clarithromycin: a review of its antimicrobial activity, pharmacokinetic properties, and therapeutic potential","volume":"44","author":"Peters","year":"1992","journal-title":"Drugs"},{"issue":"suppl A","key":"10.1378\/chest.104.5.1393_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/jac\/27.suppl_A.91","article-title":"Comparative study of clarithromycin and ampicillin in the treatment of patients with acute bacterial exacerbations of chronic bronchitis","volume":"27","author":"Bachand","year":"1991","journal-title":"J Antimicrob Chemother"},{"issue":"suppl A","key":"10.1378\/chest.104.5.1393_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/jac\/27.suppl_A.101","article-title":"Comparison of clarithromycin with ampicillin in the treatment of outpatients with acute bacterial exacerbation of chronic bronchitis","volume":"27","author":"Aldons","year":"1991","journal-title":"J Antimicrob Chemother"},{"issue":"suppl A","key":"10.1378\/chest.104.5.1393_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jac\/27.suppl_A.117","article-title":"A comparative safety and efficacy study of clarithromycin and erythromycin stearate in the treatment of community-acquired pneumonia","volume":"27","author":"Anderson","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.104.5.1393_bib20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/030006059001800212","article-title":"Clinical efficacy and tolerance of two new macrolides, clarithromycin and josamycin, in the treatment of patients with acute exacerbations of chronic bronchitis","volume":"18","author":"Fraschini","year":"1990","journal-title":"J Int Med Res"},{"issue":"suppl A","key":"10.1378\/chest.104.5.1393_bib21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/jac\/27.suppl_A.109","article-title":"Comparative study of clarithromycin and roxithromycin in the treatment of community-acquired pneumonia","volume":"27","author":"Poirier","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.104.5.1393_bib22","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/030006059001800211","article-title":"Efficacy and safety of clarithromycin versus josamycin in the treatment of hospitalized patients with bacterial pneumonia","volume":"18","author":"Straneo","year":"1990","journal-title":"J Int Med Res"},{"key":"10.1378\/chest.104.5.1393_bib23","unstructured":"National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. 3rd ed. Villanova, Pa: National Committee for Laboratory Standards, 1991"},{"key":"10.1378\/chest.104.5.1393_bib24","series-title":"Statistical methods for rates and proportions.","author":"Fleiss","year":"1981"},{"key":"10.1378\/chest.104.5.1393_bib25","unstructured":"COSTART coding symbols for thesaurus of adverse reaction terms. 3rd ed. Rockville, Md: US Department of Health and Human Services, Food and Drug Administration, 1990"},{"key":"10.1378\/chest.104.5.1393_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9343(83)91110-5","article-title":"Changing spectrum of pneumonia: news media creation or clinical reality?","volume":"74","author":"Fick","year":"1983","journal-title":"Am J Med"},{"key":"10.1378\/chest.104.5.1393_bib27","first-page":"41","article-title":"Bacterial flora of the respiratory tract in chronic bronchitis: comparison of transtracheal, fiberbronchoscopic, and oropharyngeal sampling methods","volume":"116","author":"Hass","year":"1977","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.104.5.1393_bib28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00005792-199009000-00004","article-title":"New and emerging etiologies for community acquired pneumonia and implications for therapy: a prospective multicenter study of 359 cases","volume":"69","author":"Fang","year":"1990","journal-title":"Medicine"},{"key":"10.1378\/chest.104.5.1393_bib29","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0891-5520(20)30401-3","article-title":"Pneumonia in chronic obstructive lung disease","volume":"5","author":"Griffin","year":"1991","journal-title":"Infect Dis Clin North Am"},{"key":"10.1378\/chest.104.5.1393_bib30","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0007-0971(87)90188-4","article-title":"Sputum microbiology in a district general hospital: the role of Branhamella catarrhalis","volume":"81","author":"Mannion","year":"1987","journal-title":"Br J Dis Chest"},{"issue":"suppl A","key":"10.1378\/chest.104.5.1393_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/27.suppl_A.1","article-title":"The development of macrolides: clarithromycin in perspective","volume":"27","author":"Neu","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.104.5.1393_bib32","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/clpt.1985.229","article-title":"The pharmacokinetic and bactericidal characteristics of oral cefixime","volume":"38","author":"Brittain","year":"1985","journal-title":"Clin Pharmacol Ther"},{"issue":"suppl A","key":"10.1378\/chest.104.5.1393_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/jac\/27.suppl_A.47","article-title":"Efficacy of clarithromycin against Mycoplasma pneumoniae","volume":"27","author":"Cassell","year":"1991","journal-title":"J Antimicrob Chemother"},{"issue":"suppl A","key":"10.1378\/chest.104.5.1393_bib34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jac\/27.suppl_A.43","article-title":"The in-vitro activity of clarithromycin and other macrolides against the type strain of Chlamydia pneumoniae (TWAR)","volume":"27","author":"Ridgway","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.104.5.1393_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0732-8893(92)90055-X","article-title":"Clarithromycin, a unique macrolide: a pharmacokinetic, microbiological, and clinical overview","volume":"15","author":"Hardy","year":"1992","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"suppl A","key":"10.1378\/chest.104.5.1393_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jac\/27.suppl_A.19","article-title":"The activity of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae, determined by in vitro and serum bactericidal tests","volume":"27","author":"Dabernat","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.104.5.1393_bib37","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/j.1552-4604.1991.tb03687.x","article-title":"Bactericidal activity of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae and streptococcal pathogens","volume":"31","author":"Gu","year":"1991","journal-title":"J Clin Pharmacol"},{"key":"10.1378\/chest.104.5.1393_bib38","first-page":"339","article-title":"Microscopic and bacteriologic analysis of expectorated sputum","volume":"50","author":"Murray","year":"1975","journal-title":"Mayo Clin Proc"},{"key":"10.1378\/chest.104.5.1393_bib39","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/archinte.1972.00320060083010","article-title":"Adult pneumonia in a general hospital","volume":"129","author":"Sullivan","year":"1972","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.104.5.1393_bib40","series-title":"Infectious diseases","first-page":"460","article-title":"Approach to the patient with pleuropulmonary infection","author":"La Force","year":"1992"},{"key":"10.1378\/chest.104.5.1393_bib41","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/jcm.6.5.518-527.1977","article-title":"Misinformation from sputum cultures without microscopic examination","volume":"6","author":"Heineman","year":"1977","journal-title":"J Clin Microbiol"},{"key":"10.1378\/chest.104.5.1393_bib42","first-page":"499","article-title":"Bacteria, viruses, and mycoplasmas in acute bacterial pneumonias in adults","volume":"104","author":"Fekety","year":"1971","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.104.5.1393_bib43","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1128\/jcm.25.5.758-762.1987","article-title":"Nonvalue of sputum culture in the management of lower respiratory tract infections","volume":"25","author":"Lentino","year":"1987","journal-title":"J Clin Microbiol"},{"key":"10.1378\/chest.104.5.1393_bib44","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S019594170005534X","article-title":"Ordering patterns: collection, transportation, and screening of sputum cultures in a community hospital: evaluation of methods to improve results","volume":"2","author":"Jacobson","year":"1981","journal-title":"Infection Control"},{"issue":"5N","key":"10.1378\/chest.104.5.1393_bib45","first-page":"1N","article-title":"Prognosis of patients hospitalized with community acquired pneumonia","volume":"88","author":"Fine","year":"1990","journal-title":"Am J Med"},{"key":"10.1378\/chest.104.5.1393_bib46","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1164\/ajrccm\/142.2.369","article-title":"Severe community-acquired pneumonia","volume":"142","author":"Pachon","year":"1990","journal-title":"Am Rev Respir Dis"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215422792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215422792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T04:33:16Z","timestamp":1671769996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215422792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,11]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1993,11]]}},"alternative-id":["S0012369215422792"],"URL":"https:\/\/doi.org\/10.1378\/chest.104.5.1393","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[1993,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Clarithromycin Compared to Cefixime as Outpatient Treatment of Lower Respiratory Tract Infections","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.104.5.1393","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1993 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}